The ESG Weekly: The ESG of vaccines, and shareholders say JPM must talk climate

from Sustainability Now · host MSCI ESG Research LLC

There are some promising COVID‐19 vaccines in early human trails, but we have some questions if they are successful: Who will own the patent? Who will distribute them? Who will be responsible if something goes wrong? And then we discuss the recent proxy battle at JPMorgan that ended with some interesting wins for climate activists.

Episode metadata supplied by the publisher feed · Published May 22, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

The ESG Weekly: The ESG of vaccines, and shareholders say JPM must talk climate

0:00 19:31

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Sustainability Now?

This episode is 19 minutes long.

When was this Sustainability Now episode published?

This episode was published on May 22, 2020.

Can I download this Sustainability Now episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!